Vitamin C Zinc Lozenges Market Global Report 2026

The vitamin C zinc lozenges market size has grown strongly in recent years. It will grow from $2.27 billion in 2025 to $2.47 billion in 2026 at a compound annual growth rate (CAGR) of 8.8%. The growth in the historic period can be attributed to increasing awareness of immune health and preventive care, rising incidence of seasonal cold and respiratory infections, growth in retail availability of dietary supplements, expansion of vitamin supplementation in daily nutrition habits, increasing consumer preference for convenient dosage formats.

The vitamin C zinc lozenges market size is expected to see strong growth in the next few years. It will grow to $3.49 billion in 2030 at a compound annual growth rate (CAGR) of 9.0%. The growth in the forecast period can be attributed to rising demand for preventive immune support supplements, increasing aging population requiring micronutrient supplementation, growth in personalized nutrition and functional health products, expansion of online pharmacy and direct to consumer channels, rising innovation in natural and plant based supplement formulations. Major trends in the forecast period include rising demand for immune boosting preventive healthcare supplements, increasing popularity of functional lozenges for throat soothing and cold relief, growth in sugar free and natural ingredient based supplement formulations, expansion of e commerce driven supplement accessibility and subscription models, rising consumer preference for combination micronutrient products like vitamin c and zinc blends.

The rising global emphasis on preventive healthcare is expected to support the growth of the vitamin C zinc lozenges market going forward. Preventive healthcare refers to health-related practices and measures focused on preventing diseases, enabling early detection, and maintaining overall health before the onset of illness. The growing emphasis on preventive healthcare is driven by increasing awareness regarding early disease identification and rising healthcare costs, which make prevention more cost-effective than disease treatment. This focus on preventive healthcare is increasing the adoption of vitamin C zinc lozenges by encouraging individuals to enhance immune strength through regular nutritional supplementation, helping reduce vulnerability to common infections and support overall wellness before illness occurs. For instance, in March 2026, according to Eurostat, a Luxembourg-based government agency, preventive healthcare represented the largest share of total health expenditure in 2023 among EU countries such as the Netherlands, Germany, Croatia, Italy, and Finland, accounting for between 4.6% and 5.2%. Therefore, the rising global emphasis on preventive healthcare is driving the growth of the vitamin C zinc lozenges market.

The increasing incidence of influenza is expected to drive the growth of the vitamin C zinc lozenges market going forward. Influenza is a highly contagious viral infection that mainly impacts the respiratory system and causes symptoms including fever, cough, sore throat, body aches, and fatigue. The incidence of influenza is increasing due to factors such as seasonal viral mutations that enable the emergence and spread of new flu strains, along with changing weather conditions, declining population immunity, and increased international travel that accelerate transmission. Vitamin C zinc lozenges support immune function and help relieve throat irritation associated with common cold and flu symptoms, potentially reducing the intensity and duration of symptoms linked to respiratory viral infections. For instance, in May 2026, according to the UK Health Security Agency, a UK-based government agency, between week 40 of 2022 and week 15 of 2023, 1,681 critical care admissions for confirmed influenza were reported across 108 NHS trusts in England. This was significantly higher compared with 182 admissions reported by 114 trusts during the previous season, increasing to 316 admissions by week 39 of 2022. Therefore, the rising incidence of influenza is driving the growth of the vitamin C zinc lozenges market.

The expansion of e-commerce channels is expected to drive the growth of the vitamin C zinc lozenges market going forward. E-commerce channels refer to digital platforms, including websites and mobile applications, that allow businesses to sell products and services directly to consumers through online networks. The expansion of e-commerce channels is increasing due to rising internet penetration, as greater access to online connectivity allows more consumers to shop digitally with convenience and frequency. E-commerce channels are enhancing the availability and accessibility of vitamin C zinc lozenges by improving product visibility, expanding brand reach, and enabling convenient doorstep delivery, thereby increasing consumer access to immunity-supporting supplements and encouraging repeat and impulse purchases. For instance, in February 2025, according to the Census Bureau, a US-based government agency, total e-commerce sales during the fourth quarter of 2024 increased by 9.4% compared with the fourth quarter of 2023, while total retail sales grew by 3.8% during the same period, indicating continued growth in online retail activity. Therefore, the expansion of e-commerce channels is driving the growth of the vitamin C zinc lozenges market.

Major companies operating in the vitamin c zinc lozenges market report are Holland & Barrett Limited, Jamieson Wellness Inc., Quantum Health Inc., Nature’s Sunshine Products Inc., NOW Health Group Inc., Natural Factors Nutritional Products Ltd., Life Extension Foundation Buyers Club Inc., Nature’s Way Products LLC, Swanson Health Products Inc., Vitabiotics Ltd., Zarbee’s Inc., Pharma Nord ApS, Carlson Laboratories Inc., Bluebonnet Nutrition Corporation, Comvita Limited, Herbion International Inc., Superior Source Vitamins LLC, Viridian Nutrition Ltd., Pharmavite LLC, Reckitt Benckiser Group plc, Mondelēz International Inc., Ricola Group AG, Sambucol USA.

North America was the dominating region in the vitamin C zinc lozenges market in 2025. Asia-Pacific is expected to be the rapidly growing region in the forecast period. The regions covered in the vitamin C zinc lozenges market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the vitamin C zinc lozenges market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

This product will be delivered within 3-5 business days.